GCO Earnings

Quarterly EPS
$-0.91
Q2 2025
$-1.76
Q3 2025
$3.20
Q4 2025
$-2.02
Q1 2026
$-1.79
Q2 2026
$0.52
Q3 2026
$4.60
Q4 2026
$-1.42
Q1 2027
Latest Revenue487.0M
Latest Net Income-14814000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027-$1.42487.0M-14814000+2.8%+29.7%
Q4 2026$4.60799.9M47.6M+7.2%+43.7%
Q3 2026$0.52616.2M5.4M+3.3%+129.5%
Q2 2026-$1.79546.0M-18471000+4.0%-96.7%
Q1 2026-$2.02474.0M-21227000+3.6%+9.4%
Q4 2025$3.20745.9M34.4M+0.9%+28.5%
Q3 2025-$1.76596.3M-18932000+2.9%-393.3%
Q2 2025-$0.91525.2M-9992000+0.4%+67.4%
Q1 2025-$2.23457.6M-24347000
Q4 2024$2.49739.0M27.2M
Q3 2024$0.60579.3M6.5M
Q2 2024-$2.79523.0M-31665000
Genes (GCO) — Earnings